1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
2.3. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Drug, 2025 (US$ Million)
2.4. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Infection, 2025 (US$ Million)
2.5. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Pathogen, 2025 (US$ Million)
2.6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Geography, 2025 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2025
3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
3.2. Strategies Adopted by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Delafloxacin
5.3.2. Vancomycin
5.3.3. Ceftaroline fosamil
5.3.4. Telvancin
5.3.5. Oritavancin
5.3.6. Tedizolid
5.3.7. Daptomycin
5.3.8. Tigecycline
5.3.9. Linezolid
5.3.10. TMP-SMZ
5.3.11. Others (Doxycycline, Levofloxacin, Metronidazole, and Others)
6. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Cellulitis
6.3.2. Abscess/Boil/Cyst
6.3.3. Surgical Wound
6.3.4. Traumatic Wound
7. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Methicillin sensitive Staphylococcus aureus (MSSA)
7.3.2. Methicillin resistant Staphylococcus aureus (MRSA)
7.3.3. Beta-hemolytic Streptococcus
7.3.4. Escherichia coli
7.3.5. Enterococcus faecalis
7.3.6. Pseudomonas aeruginosa
7.3.7. Others
8. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
8.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
8.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
8.5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2024-2034, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
8.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
8.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
8.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
8.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
8.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
8.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
9. UK and European Union Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
9.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
9.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
9.5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2024-2034, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
9.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
9.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
9.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
9.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
9.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
9.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
9.5.1.4.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
9.5.1.4.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
9.5.1.5. France
9.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
9.5.1.5.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
9.5.1.5.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
9.5.1.6.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
9.5.1.6.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
10. Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
10.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
10.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
10.5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2024-2034, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
10.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
10.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
10.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
10.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
10.5.1.3. India
10.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
10.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
10.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
10.5.1.4.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
10.5.1.4.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
10.5.1.5.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
10.5.1.5.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
10.5.1.6.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
10.5.1.6.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
11. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
11.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
11.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
11.5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2024-2034, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
11.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
11.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
11.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
11.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
11.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
11.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
12. Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
12.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
12.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
12.5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2024-2034, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
12.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
12.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
12.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
12.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2024-2034, USD (Million)
12.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2024-2034, USD (Million)
12.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2024-2034, USD (Million)
13. Company Profile
13.1. Furiex Pharmaceuticals, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. GlaxoSmithKline plc
13.3. Melinta Therapeutics, Inc.
13.4. Debiopharm International S.A.
13.5. MerLion Pharmaceuticals Pte Ltd.
13.6. Durata Therapeutics, Inc.
13.7. Paratek Pharmaceuticals, Inc.
13.8. Cempra, Inc.
13.9. Abbott Laboratories, Inc.
13.10. Actelion Pharmaceuticals Ltd.
13.11. Albany Molecular Research, Inc.
13.12. Allergan plc.
13.13. AstraZeneca
13.14. Bayer AG
13.15. Macrolide Pharmaceuticals, Inc.
13.16. Merck & Co, Inc.
13.17. Pfizer, Inc.
13.18. Sanofi
13.19. Teva Pharmaceuticals Industries Ltd.
13.20. Zavante Therapeutics, Inc.
